Stay updated with breaking news from Gene Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OpGen, Inc. (NASDAQ:OPGN – Get Free Report) saw a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 7,800 shares, a decrease of 95.9% from the April 30th total of 191,400 shares. Based on an average daily volume of 173,300 shares, the short-interest ratio is […]
StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a sell rating on the medical research company’s stock. OpGen Trading Up 0.9 % NASDAQ OPGN opened at $3.30 on Friday. OpGen has a 12 month low of $1.65 and a […]
Stock analysts at StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the medical research company’s stock. OpGen Trading Up 0.9 % Shares of OPGN stock opened at $3.30 on Friday. OpGen has a 12-month low of […]
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The
StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report report published on Wednesday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Performance Shares of OPGN opened at $0.47 on Wednesday. The company’s 50-day simple moving average is $0.57 and its 200-day simple moving […]